Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Actuary: drug costs and deferred care shaped 2020 plan experience; board weighs rate impacts

San Francisco Health Service System Board · March 11, 2021
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Aon presented 2020 claims experience showing medical claim suppression during the pandemic and rising prescription drug and specialty drug costs; the board heard concerns about deferred care and approved recommendations on stabilization use that will lower 2022 rates modestly.

Mike Clark of Aon presented detailed 2020 claims and utilization analysis for Blue Shield HMO plans and the PPO city plan (administered by UnitedHealthcare in 2020 and scheduled to transition to Blue Shield on Jan. 1, 2022). Clark said the combination of pandemic‑related suppression in medical services and increased prescription drug costs produced mixed results: overall plan expenses per member rose modestly while prescription drug…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans